Compounds > 4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol
Page last updated: 2024-10-21

4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol and Pain

4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol has been researched along with Pain in 2 studies

4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol: inhibitor of GABA uptake systems; RN given refers to parent cpd

Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zarrindast, MR2
Rezayat, M2
Ghanipoor, N1
Parvini, S2
Tabarrai, E1
Pirali, M1

Other Studies

2 other studies available for 4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol and Pain

ArticleYear
Interactions between antinociception induced by cholecystokinin antagonists and GABA agonists in the tail-flick test.
    Pharmacology & toxicology, 1998, Volume: 83, Issue:4

    Topics: Animals; Baclofen; Benzodiazepinones; Devazepide; Dose-Response Relationship, Drug; Drug Interaction

1998
Effects of CCK antagonists on GABA mechanism-induced antinociception in the formalin test.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 9, Issue:1-2

    Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Baclofen; Dose-Response Relationship, Drug; F

1999